OR WAIT null SECS
November 01, 2005
Biomanufacturing managers believe the current lack of adequately trained personnel is one of the most serious problems facing the biomanufacturing industry.
October 27, 2005
Industry, FDA, and World Health Agencies Boost Pandemic Preparedness
October 06, 2005
Collaboration Targets Single-Shot Japanese Encephalitis Vaccine
September 02, 2005
A fleet of pharmaceutical manufacturers have green lighted new bar coding and e-pedigree pilots using electronic barcodes. But is Industry ready for full-scale RFID?
September 01, 2005
Contract manufacturers serving the biopharmaceutical market add capacity in a bet on renewed growth for biomanufacturing.
August 02, 2005
Being the first to gain the most is a fundamental principle in the generics business because several companies compete to create generics of successful products going off patent. For a generics company to maintain revenue growth in a market in which product prices continue to fall, it must secure a continuous flow of new products, with quality and speed to market being key drivers. Thus, generics companies must be highly skilled in product and process development (1), the generics business, and achieving bioequivalence-the most critical development area.
July 29, 2005
Microbioreactor Array System Boost Cell Culture Capacity
Protein Refolding Technology Improves Yields
July 02, 2005
Can macromolecular processes learn from small-molecule experience? Burdened by exploding bioreactor productivity, architects of downstream bioseparation technology are looking into the drug industry's past for inspiration, while small-molecule companies adopt techniques pioneered by biotechnology. (The first of three articles on the current state of separations.)
June 30, 2005
FDA Posts Q5E Biotech and Biological Products Comparability Guideline